Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, ...

Mounjaro (Tirzepatide), a groundbreaking GLP-1 receptor agonist targeting GIP receptors, is now available in India for ...

Lexaria Bioscience (LEXX) announced pharmacokinetic results from Human Study #3 or GLP-1-H24-3, comparing an oral version of ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Analysts maintain optimistic price targets, with additional insights and financial metrics available ... DehydraTECH-tirzepatide capsules compared to the conventional Zepbound injection.

Zepbound® is currently only available as a once-weekly ... The Zepbound® formulation had a strength of 2.5 mg tirzepatide administered once via injection with the subject monitored over the ...